172 related articles for article (PubMed ID: 26285687)
21. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
Xu Z; Liu S; Kang Y; Wang M
Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
[TBL] [Abstract][Full Text] [Related]
22. A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo.
Tarasenko N; Cutts SM; Phillips DR; Berkovitch-Luria G; Bardugo-Nissim E; Weitman M; Nudelman A; Rephaeli A
Biochem Pharmacol; 2014 Mar; 88(2):158-68. PubMed ID: 24463168
[TBL] [Abstract][Full Text] [Related]
23. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
[TBL] [Abstract][Full Text] [Related]
24. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
Wu G; Wang Z; Bian X; Du X; Wei C
Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
[TBL] [Abstract][Full Text] [Related]
25. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
[TBL] [Abstract][Full Text] [Related]
26. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery.
Deepagan VG; Kwon S; You DG; Nguyen VQ; Um W; Ko H; Lee H; Jo DG; Kang YM; Park JH
Biomaterials; 2016 Oct; 103():56-66. PubMed ID: 27372421
[TBL] [Abstract][Full Text] [Related]
27. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
28. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo chemo-phototherapy of magnetic TiO2 drug delivery system formed by pH-sensitive coordination bond.
Zhang H; Ji Y; Chen Q; Zhu X; Zhang X; Tan Z; Tian Q; Yang X; Zhang Z
J Biomater Appl; 2016 Oct; 31(4):568-581. PubMed ID: 27334128
[TBL] [Abstract][Full Text] [Related]
30. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
31. pH-Responsive Nanoscale Coordination Polymer for Efficient Drug Delivery and Real-Time Release Monitoring.
Han K; Zhang WY; Zhang J; Ma ZY; Han HY
Adv Healthc Mater; 2017 Oct; 6(19):. PubMed ID: 28714280
[TBL] [Abstract][Full Text] [Related]
32. Smac therapeutic Peptide nanoparticles inducing apoptosis of cancer cells for combination chemotherapy with Doxorubicin.
Li M; Liu P; Gao G; Deng J; Pan Z; Wu X; Xie G; Yue C; Cho CH; Ma Y; Cai L
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8005-12. PubMed ID: 25815797
[TBL] [Abstract][Full Text] [Related]
33. Nano-Aggregates of Doxorubicin-Conjugated Methoxy Poly(ethylene glycol)-b-Carboxymethyl Dextran Copolymer.
Lee SJ; Kang MS; Oh JS; Jeong YI; Park IK; Lee HC
J Nanosci Nanotechnol; 2015 Aug; 15(8):5566-70. PubMed ID: 26369118
[TBL] [Abstract][Full Text] [Related]
34. Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
Kim N; Kwon S; Kwon G; Song N; Jo H; Kim C; Park S; Lee D
J Control Release; 2024 May; 369():351-362. PubMed ID: 38552963
[TBL] [Abstract][Full Text] [Related]
35. Folic acid protected silver nanocarriers for targeted drug delivery.
Wang Y; Newell BB; Irudayaraj J
J Biomed Nanotechnol; 2012 Oct; 8(5):751-9. PubMed ID: 22888745
[TBL] [Abstract][Full Text] [Related]
36. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K
Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095
[TBL] [Abstract][Full Text] [Related]
37. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy.
Shim MK; Park J; Yoon HY; Lee S; Um W; Kim JH; Kang SW; Seo JW; Hyun SW; Park JH; Byun Y; Kwon IC; Kim K
J Control Release; 2019 Jan; 294():376-389. PubMed ID: 30550940
[TBL] [Abstract][Full Text] [Related]
38. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
39. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery.
Mehra NK; Jain NK
Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904
[TBL] [Abstract][Full Text] [Related]
40. Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.
Song H; Zhang J; Wang W; Huang P; Zhang Y; Liu J; Li C; Kong D
Colloids Surf B Biointerfaces; 2015 Dec; 136():365-74. PubMed ID: 26433349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
